Information on Stem Cell Research

Skip secondary menu

Table of Contents (click to jump to sections)

Funding Opportunities at NINDS
NINDS Contact Information
Funding Opportunities at Other NIH Institutes
Courses & Training Programs
NIH Policy & Implementation
FDA Information and Regulatory Guidance
Press Releases from NINDS
News articles from NINDS

Funding Opportunities at NINDS

Top

NINDS Contact Information


David Owens, Ph.D.
Program Director
do47h@nih.gov
Phone: (301) 496-1447
Top

View all NIH-wide stem cell related announcements listed by type of stem cell being researched.
View all NIH-wide stem cell related announcements listed by NIH Institute
Top

Courses & Training Programs

Top

NIH Policy and Implementation

Top

FDA Information and Regulatory Guidances

  • Center for Biologics Evaluation and Research (CBER) http://www.fda.gov/cber/
  • CBER Guidances / Guidelines / Points to Consider - a comprehensive listing of documents that provides information detailing CBER's regulatory approach for a various categories of biological products. http://www.fda.gov/cber/guidelines.htm
  • FDA/CBER Tissue Action Plan - details CBER's strategy for the regulation of cellular and tissue-based products. http://www.fda.gov/cber/tiss.htm
  • Cellular therapies developed from human embryonic stem cell lines initially maintained by culturing on murine feeder cell layers are considered xenotransplantation products - FDA/CBER Xenotransplantation Action Plan details a comprehensive regulatory approach for xenotransplantation regulation. http://www.fda.gov/cber/xap/xap.htm
  • Submitting an Investigational New Drug (IND) Application to FDA/CBER http://www.fda.gov/cber/ind/ind.htm

Top

Press Releases from NINDS

Top

News articles from NINDS

Top

Last updated August 01, 2008